Foghorn Therapeutics Inc (FHTX)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -122.333 | -156.355 | -49.508 | -26.135 | -23.551 | -28.496 |
| Return on Equity (%) | 134.123 | 80.334 | -236.544 | -83.371 | -224.538 | 255.393 |
| Return on Invested Capital (%) | -135.531 | -221.219 | -80.149 | -78.697 | -263.932 | 267.019 |
| Operating Margin (%) | N/A | N/A | -15772.326 | -7537.074 | -566.268 | -275.801 |
| Net Profit Margin (%) | N/A | N/A | -16000 | -7681.577 | -566.268 | -288.174 |
| Book Value Per Share | 4.974 | -0.163 | 3.973 | 2.346 | 0.003 | -1.828 |
| Earnings Per Share | -4.097 | -5.674 | -1.87 | -2.453 | -2.605 | -2.331 |
| Cash Per Share | 6.225 | 1.663 | 2.522 | 2.449 | 1.249 | 1.903 |
| Working Capital Per Share | 5.746 | 0.47 | 4.671 | 9.948 | 7.085 | 4.305 |
| Operating Profit Per Share | N/A | N/A | 0.012 | 0.032 | 0.46 | 0.809 |
| EBIT Per Share | -4.097 | -5.674 | -1.87 | -2.453 | -2.605 | -2.231 |
| EBITDA Per Share | -4.097 | -5.674 | -1.87 | -2.453 | -2.605 | -2.231 |
| Free Cash Flow Per Share | -3.916 | -5.643 | -1.466 | -2.451 | -2.655 | -2.384 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | 11.68 | 1.335 | 10.118 | 9.438 | 6.365 | 4.11 |
| Quick Ratio | 11.57 | 1.227 | 9.857 | 3.169 | 6.264 | 4.005 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 6.43M | 9.01M | 36.79M | 41.3M | 41.8M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | N/A | 41.8M | 41.8M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | -563.722 | N/A | N/A | N/A | -495.366 |
| Net Profit Margin (%) | N/A | N/A | N/A | -574.27 | N/A | N/A | N/A | -495.366 |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | 5.748 | N/A | N/A | N/A | 4.063 |
| Quick Ratio | N/A | N/A | N/A | 5.663 | N/A | N/A | N/A | 3.969 |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 277.66M |
| Price to Earnings Ratio | -2.92 |
| Price to Sales Ratio | 8.43 |
| Price to Cash Ratio | 3.58 |
| Price to Book Ratio | -3.73 |
| Dividend Yield | - |
| Shares Outstanding | 42.59M |
| Average Volume (1 week) | 63.85k |
| Average Volume (1 Month) | 139.59k |
| 52 Week Change | -12.89% |
| 52 Week High | 9.97 |
| 52 Week Low | 2.70 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
